Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.60 |
| ▸ | PPARG | P37231 | 7/20 | 0.60 |
| ▸ | PPARD | Q03181 | 7/20 | 0.60 |
| ▸ | PPARA | Q07869 | 7/20 | 0.60 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.60 |
| ▸ | TSHR | P16473 | 5/20 | 0.60 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | TLR2 | O60603 | 2/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | FABP4 | P15090 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.60 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | ESR1 | P03372 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | PDE4A | P27815 | 1/20 | 0.60 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4633330 | 1.00 | GPR84 (0.60) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL1768652 | 1.00 | GPR84 (0.60) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL6507588 | 1.00 | — | — | |
| SCHEMBL2524053 | 1.00 | GPR84 (0.60) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL3422866 | 1.00 | GPR84 (0.60) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL2969247 | 1.00 | GPR84 (0.60) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL7461021 | 1.00 | GPR84 (0.60) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL18035657 | 1.00 | GPR84 (0.60) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL1685840 | 1.00 | GPR84 (0.60) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL27497814 | 1.00 | GPR84 (0.60) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110104084-A1 | NOVEL COMPOSITIONS BASED ON ETHERS OF ALKYL POLYOSIDES AND ON ALKYL GLYCERYL ETHERS, USE THEREOF AS AN EMULSIFIER AND COSMETIC COMPOSITIONS CONTAINING SAME | Societe d'Exploitation de Products Pour Les Industries Chimiques SEPPIC | 2011-05-05 | — | — | US | disclosed |
| EP-2307433-A2 | NOVEL COMPOSITIONS BASED ON ETHERS OF ALKYL POLYOSIDES AND ON ALKYL GLYCERYL ETHERS, USE THEREOF AS AN EMULSIFIER AND COSMETIC COMPOSITIONS CONTAINING SAME | Societe D'Exploitation De Produits Pour Les Industries Chimiques Seppic (FR) | 2011-04-13 | — | — | EP | disclosed |
| EP-2044096-B1 | NEW SUGAR DERIVATIVES, METHOD FOR PREPARATION THEREOF, THEIR USE AS SURFACE-ACTIVE AGENTS | SEPPIC SA (FR) | 2010-06-16 | — | — | EP | disclosed |
| US-20100130581-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN | THE UNIVERSITY OF QUEENSLAND | 2010-05-27 | — | — | US | disclosed |
| US-7671118-B2 | Stabilizer system for stabilizing halogen-containing polymers | Chemtura Vinyl Additives, GmbH (DE) | 2010-03-02 | — | — | US | disclosed |
| WO-2009153509-A2 | NOVEL COMPOSITIONS BASED ON ETHERS OF ALKYL POLYOSIDES AND ON ALKYL GLYCERYL ETHERS, USE THEREOF AS AN EMULSIFIER AND COSMETIC COMPOSITIONS CONTAINING SAME | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2009-12-23 | — | — | WO | disclosed |
| US-20090209485-A1 | MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES | PARISH CHRISTOPHER RICHARD | 2009-08-20 | — | — | US | disclosed |
| EP-2044096-A2 | NEW SUGAR DERIVATIVES, METHOD FOR PREPARATION THEREOF, THEIR USE AS SURFACE-ACTIVE AGENTS | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES-SEPPIC (FR) | 2009-04-08 | — | — | EP | disclosed |
| EP-2007790-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN | THE UNIVERSITY OF QUEENSLAND (AU) | 2008-12-31 | — | — | EP | disclosed |
| EP-1318799-B1 | STABLE DOSAGE FORMS CONTAINING UBIQUINONES | ABBOTT GMBH & CO KG (DE) | 2008-12-03 | — | — | EP | disclosed |
| EP-1368423-A1 | CHLORATE-CONTAINING STABILIZER SYSTEM WITH NITROGEN-CONTAINING SYNERGISTS FOR STABILIZING HALOGEN-CONTAINING POLYMERS | Crompton Vinyl Additives GmbH (DE) | 2003-12-10 | — | — | EP | disclosed |
| EP-1318799-A2 | STABLE DOSAGE FORMS CONTAINING UBIQUINONES | Abbott GmbH & Co. KG (DE) | 2003-06-18 | — | — | EP | disclosed |
| WO-2002072684-A1 | CHLORATE-CONTAINING STABILIZER SYSTEM WITH NITROGEN-CONTAINING SYNERGISTS FOR STABILIZING HALOGEN-CONTAINING POLYMERS | CROMPTON VINYL ADDITIVES GMBH (DE) | 2002-09-19 | — | — | WO | disclosed |
| WO-2002024184-A2 | MECHANICALLY STABLE DOSAGE FORMS CONTAINING UBIQUINONES | ABBOTT GMBH & CO. KG (DE) | 2002-03-28 | — | — | WO | disclosed |
| EP-1101485-A1 | Viscosity stabilized compositions comprising a zeolite and a solid fatty alcohol | AVON PRODUCTS, INC. (US) | 2001-05-23 | — | — | EP | disclosed |
| US-5066648-A | Transdermal drug delivery, viricides, enzyme inhibitors | MERCK & CO., INC. (US) | 1991-11-19 | — | — | US | disclosed |
| US-4970206-A | TRANSDERMAL DRUG DELIVERY | MERCK & CO., INC. (US) | 1990-11-13 | — | — | US | disclosed |
| US-4847250-A | HYPOTENSIVE AGENTS | MERCK & CO., INC. (US) | 1989-07-11 | — | — | US | disclosed |
| US-4762851-A | ANTIINFLAMMATORY AGENTS | MERCK & CO., INC. (US) | 1988-08-09 | — | — | US | disclosed |
| EP-0227531-A2 | Pyroglutamic acid esters used as dermal penetration enhancers for drugs | MERCK & CO. INC. (US) | 1987-07-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130581-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN | OPRL1, CRH, OPRK1 | GPR84 648/4885PPARG 1906/4885PPARD 2000/4885 |
| US-20110104084-A1 | NOVEL COMPOSITIONS BASED ON ETHERS OF ALKYL POLYOSIDES AND ON ALKYL GLYCERYL ETHERS, USE THEREOF AS AN EMULSIFIER AND COSMETIC COMPOSITIONS CONTAINING SAME | TYR, GK, UGCG | GPR84 714/4885PPARG 66/4885PPARD 670/4885 |
| US-20090209485-A1 | MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES | FLT4, UGGT1, FLT1 | GPR84 506/4885PPARG 1632/4885PPARD 2264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.